2022 Literature Analysis

Registration Options

Activity Dates: 02/24/2022 - 12/06/2022

Sign in (or create a FREE account) to register or access your existing registrations

Target Audience

This self-study activity serves as an educational tool for pharmacists seeking Board Certified Psychiatric Pharmacist (BCPP) Recertification credit and other pharmacists and health care providers seeking advanced education in patient management, disease state management, information management, and health policy and practice management in the field of psychiatric pharmacy.

Content

The articles selected by CPNP Recertification Editorial Board for the Literature Analysis are based on a 7-year curriculum. This curriculum is developed using the Board of Pharmaceutical Specialties' Content Outline for the Psychiatric Pharmacy Specialty Certification Examination as a guideline. Since CPNP became the sole BCPP Recertification provider in 2008, the articles are chosen to cover the three content domains - Domain I: Patient Management, Domain 2: Information Management, Domain 3: Health Policy and Practice Management.

The Literature Analysis is self-study, online only, application-based continuing pharmacy education (CPE) activity. An application-based CPE activity requires that participants apply the information learned. The examination for this product often features case studies requiring that the participant apply the principles learned through the readings. The 2022 Literature Analysis product is debuting a new format for 2 of the 10 hours of the product. Article 1 on “Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer’s Disease” is complimented by a 1 hour recorded webinar by Dr. Ryan Carnahan, PharmD, BCPP, assisting you as the learner in making accurate interpretations of the article. You are encouraged to read the article first and then watch the webinar while keeping the article open for frequent referral back to sections as guided by Dr. Carnahan. Including this new format, the Literature Analysis components consist of:

  • Electronic access to all required journal articles needed to prepare for the online assessment.
  • The webinar that accompanies article #1 as provided by Dr. Ryan Carnahan.
  • For pharmacists, 10 hours of ACPE credit and 10 hours of BCPP Recertification credit achieved by successfully completing the online CPNP recertification examination.
  • Access to the CPNP testing center with exam submission due by or on November 30, 2022.
  • The opportunity to provide CPNP feedback on the entire product including this new format for 2 out of the 10 hours of content.

Course Requirements

To satisfactorily complete the Literature Analysis and receive 10 hours of BCPP Recertification and ACPE credit, candidates must meet the following requirements:

  1. Abide by a confidentiality and honesty statement requiring individual completion of the recertification education.
  2. Complete an online assessment on or before the deadline of November 30, 2022.
  3. Receive a passing grade (72%).
  4. Partial credit is not available for individual topics within the Literature Analysis programming; it is either all 10 hours of Literature Analysis programming credit or none.

You will proceed through the following steps to satisfactorily complete this course:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Complete the pre-test before starting the activity.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • Wait for the official review of exam questions within 4 weeks following the closing date.
  • Receive a passing grade (72%).
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Participants successfully passing the required assessment/examination will obtain both ACPE and BCPP recertification credit. Credit is awarded in the calendar year the assessment is completed. ACPE credit is reported through CPE Monitor within days of examination submission, while BCPP recertification credit is reported to BPS within 6 weeks after the examination deadline.

Learning Objectives

Article Number Topic Article and Learning Objectives
1 Alzheimer's with Clinical vs Statistical Significance

Article 1 on “Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer’s Disease” is complimented by a 1 hour recorded webinar by Dr. Ryan Carnahan, PharmD, BCPP, assisting you as the learner in making accurate interpretations of the article. You are encouraged to read the article first and then watch the webinar while keeping the article open for frequent referral back to sections as guided by Dr. Carnahan.

Li DD, Zhang YH, Zhang W, Zhao P.  Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer’s Disease.  Frontiers in Neuroscience 2019;13.

  1. Discuss the statistical comparisons in a meta-analysis, including the differentiation of concepts of clinical versus statistical significance.
  2. Explain the methods, results and interpretations of a meta-analysis of cognitive enhancing medications in Alzheimer’s disease.
  3. Recommend cognitive enhancing medications for a patient with Alzheimer’s disease based on efficacy, safety, and patient-centered factors.
2 Mood Disorders in Women

Baker AS, Wales R, Noe O, et al. The course of ADHD during pregnancy. J Atten Disord 2020; 1-6.

  1. Evaluate changes in symptom control for psychiatric disorders based on use of or changes to attention-deficit/hyperactivity disorder (ADHD) medications during pregnancy.
  2. Assess the risks and/or benefits of psychostimulant use in pregnant patients.
3 Collaborative Practice Agreements

Centers for Disease Control and Prevention. Advancing Team-Based Care Through Collaborative Practice Agreements: A Resource and Implementation Guide for Adding Pharmacists to the Care Team. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Department of Health and Human Services; 2017.

  1. Propose pharmacy services that commonly require a collaborative practice agreement (CPA).
  2. Implement strategies for building a relationship with providers who are interested in entering a CPA.
  3. Develop a collaborative practice agreement for the management of psychiatric disease states.
  4. Recommend revenue sources to promote a sustainable business model for a CPA.
4 Restless Leg Syndrome

Romero-Peralta S, Cano-Pumarega I, Garcia-Borreguero D. Emerging Concepts of the Pathophysiology and Adverse Outcomes of Restless Legs Syndrome. Chest. 2020 Sep;158(3):1218-1229

  1. Evaluate a patient for restless legs syndrome.
  2. Create a treatment plan for a patient diagnosed with restless legs syndrome.
  3. Monitor for adverse drug effects and disease-related complications in patients with restless legs syndrome.
5 Procedures to Evaluate Effectiveness of Medication Education

Dunkley KA, et al. Implementation of a medication education training program for student pharmacists employed within an academic medical center. Am J Health-Syst Pharm. 2020; 77: 206-214

  1. Assess potential barriers to providing medication education in an inpatient hospital setting.
  2. Create a student pharmacist-led medication education training program for an inpatient hospital setting.
  3. Develop a plan to assess the effectiveness of a student pharmacist-led medication education program.
6 Parkinson's Disease

Hayes MT. Parkinson’s Disease and Parkinsonism. Am J Med. 2019; 132: 802-807.

  1. Evaluate the risk factors, pathology, and symptoms of Parkinson’s disease.
  2. Develop a treatment plan for a patient with Parkinson’s disease.
  3. Differentiate Parkinson’s disease from drug-induced parkinsonism and other neurodegenerative diseases.
7 Information Technology

Rathod P, et al. Patient Education and Counseling 102 (2019) 952–960. An evaluation of the suitability, readability, and quality of online resources for self-management of depression.

  1. Evaluate online depression self-management resources based on their readability, suitability and/or quality.
  2. Educate healthcare providers and/or patients on the benefits and/or limitations of online self-management resources for depression.
  3. Design an evaluation process for online self-management resources for depression.
8 Anxiety Disorders

Naderi S, et al. Psychiatry and Clinical Neurosciences 73: 169–174, 2019.Amantadine as adjuvant therapy in the treatment of moderate to severe obsessive-compulsive disorder.

  1. Evaluate the efficacy of amantadine in treatment of treatment-resistant OCD.
  2. Choose patients who may be appropriate for treatment with amantadine.
  3. Construct an evidence-based and patient-centered treatment plan for a patient with treatment-resistant OCD.
9 Halmark Trial

Kapur J, Elm J, Chamberlain JM, et al. Randomized trial of three anticonvulsant medications for status epilepticus. NEJM 2019; 381: 2103-2113.

  1. Educate clinicians on this landmark clinical trial for application in clinical practice.
  2. Analyze the Established Status Epilepticus Treatment Trial (ESETT) design, limitations, and/or results in order to provide evidence-based recommendations.
  3. Develop a quality improvement plan to optimize the treatment of status epilepticus.

Continuing Education Credit and Disclosures

Activity Dates: 02/24/2022 - 12/06/2022
ACPE Contact Hours: 10
ACPE Number: 0284-0000-22-030-H01-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Literature Analysis product is an application-based program approved for 10 hours of ACPE credit. To receive ACPE credit, pharmacists completing this programming are required to complete an evaluation of the course as well as pass an online examination. BCPP Recertification credit is earned and reported within the year the assessment is successfully completed.

Board Certified Psychiatric Pharmacists (BCPPs) may also receive 10 hours of BCPP Recertification Credit for the Literature Analysis upon successful completion of an online examination.

The College of Psychiatric and Neurologic Pharmacists is approved as a Professional Development Provider for the Board Certified Psychiatric Pharmacist (BCPP) specialty by the Board of Pharmacy Specialties (BPS). (Applicable to programs where individual sessions are listed on separate course pages). This course is part of a 10 hour BCPP recertification product earned after successful completion of the associated BCPP recertification examination for the full product.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.